cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Applied Therapeutics Inc
4 own
12 watching
Current Price
$1.12
$0.02
(1.82%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
39.28M
52-Week High
52-Week High
2.73
52-Week Low
52-Week Low
0.4995
Average Volume
Average Volume
0.14M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization39.28M
icon52-Week High2.73
icon52-Week Low0.4995
iconAverage Volume0.14M
iconDividend Yield--
iconP/E Ratio--
What does the Applied Therapeutics Inc do?
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Read More
How much money does Applied Therapeutics Inc make?
News & Events about Applied Therapeutics Inc.
PR Newswire
1month ago
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Applied Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Applied Therapeutics, Inc. for Potential Breaches of Fiduciary Duty...
Globe Newswire
6 months ago
Completed public equity offering with gross proceeds of $30 million Granted orphan medicinal product designation by the EMA for AT-007 for treatment of Galactosemia Continued progress in three registrational Phase 3 trials in areas of high unmet medical need, with multiple clinical milestones ...
Globe Newswire
7 months ago
NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the Company), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the pricing of...
Globe Newswire
8 months ago
NEW YORK, June 03, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced designation of AT-007 (...
Globe Newswire
10 months ago
NEW YORK, March 25, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Corcept Therapeutics, Inc. (NASDAQ: CORT), Verra Mobility Corp. (NASDAQ: VRRM), Core Scientific, Inc. (NASDAQ: CORZ), and Applied ...
Frequently Asked Questions
Frequently Asked Questions
What is Applied Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Applied Therapeutics Inc shares?
plus_minus_icon
How can I buy Applied Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Applied Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Applied Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Applied Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Applied Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Applied Therapeutics Inc?
plus_minus_icon
What percentage is Applied Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Applied Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.12
$0.02
(1.82%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00